HAEMONINE

This brand name is authorized in Austria, Tunisia, Turkey, United Kingdom

Active ingredients

The drug HAEMONINE contains one active pharmaceutical ingredient (API):

1 Human plasma coagulation factor IX concentrate UNII 6U90Y1795T - COAGULATION FACTOR IX HUMAN

Factor IX is a single chain glycoprotein with a molecular mass of about 68,000 Dalton. It is a vitamin-K dependent coagulation factor and it is synthesised in the liver. Factor IX is activated by factor XIa in the intrinsic coagulation pathway and by the factor VII/tissue factor complex in the extrinsic pathway. Activated factor IX, in combination with activated factor VIII, activates factor X. Read about Coagulation factor IX

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
HAEMONINE Powder and solvent for solution for injection	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B02BD04	Coagulation factor IX	B Blood and blood forming organs → B02 Antihemorrhagics → B02B Vitamin K and other hemostatics → B02BD Blood coagulation factors
Discover more medicines within B02BD04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 327515, 327517
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 8153081H, 8153082H
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8682109319874, 8682109319881